Toxicology Market Analysis and Reports | USA Conference Series

Market Analysis - Toxicology 2018

Toxicology Market Analysis | Market Reports | USA| Europe | Asia | Middle East

The global in vitro toxicology testing market is expected to reach USD 27.36 Billion by 2021 from USD 14.15 Billion in 2016, at a CAGR of 14.1% from 2016 to 2021 at a CAGR of 9.8% during the forecast period from 2016 to 2021. Opposition to animal testing, new & promising technologies, increasing R&D to detect toxicity at early stages and insufficient databases to facilitate the use of in vitro test methods are the primary growth drivers for this market during the forecast period (2016–2021). However, lack of in vitro models to detect autoimmunity and immunostimulation and predictive ability of in vitro testing over in vivo testing may hinder the growth of this market. Predictive in-vitro toxicology is the new cutting edge in biopharmaceutical research. It is considered one of the most significant steps in drug discovery. Predictive in-vitro toxicology will improve the quality and quantity of drugs entering clinical studies. It improves the safety and efficiency of new compounds and allows compounds to be arranged early in the development process. Earlier and more lucrative identification of potential mechanisms that cause adverse drug reactions have significant potential for improving consequences in drug discovery. Regulatory drivers play a large role in toxicology, determining the specific parameters of tests that have been explicitly required. Diverse factors play instrumental roles in regulating the market for toxicology and pharmacology.

The below statistical analysis helps understand the scenario better: